Clone T11D7e is useful for removal of T lymphocytes from cell populations by complement mediated cytotoxicity.
| Inventor | Institute |
|---|---|
| Phil Lake | University College London (UCL) |
| Cat. #: | 152626 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cell biology;Immunology;Neurobiology;Stem cell biology |
| Application: | FACS ; Fn |
| Target: | CD90, Thy1.1 |
| Reactivity: | Mouse ; Rat |
| Clone: | T11D7e |
| Host: | Mouse |
| Class: | Monoclonal |
| Alternate name: | Thy-1 Cell Surface Antigen; Thy-1 Antigen; CDw9; CD9 |
|---|---|
| Product description: | CD90 (Thy1.1) is a monomorphic determinant in rat but polymorphic in mice. Anti-CD90 [T11D7e] reacts with Thy1.1 mice e.g. AKR and FVB mice, but not Thy1.2 mice such as CBA and BALB/c. Clone T11D7e is useful for removal of T lymphocytes from cell populations by complement mediated cytotoxicity. CD90 is a mesenchymal cell marker |
| Conjugation: | Unconjugated |
| Isotype: | IgM |
| Immunogen: | Xenogenic rat thymocytes |
| Myeloma used: | P3/NS1/1-Ag4.1 |
| Target background: | CD90 (Thy1.1) is a monomorphic determinant in rat but polymorphic in mice. Anti-CD90 [T11D7e] reacts with Thy1.1 mice e.g. AKR and FVB mice, but not Thy1.2 mice such as CBA and BALB/c. Clone T11D7e is useful for removal of T lymphocytes from cell populations by complement mediated cytotoxicity. CD90 is a mesenchymal cell marker |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 0.9-1.1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Mahanthappa et al. 1996. J Neurosci. 16(15):4673-83. PMID: 8764655. Glial growth factor 2, a soluble neuregulin, directly increases Schwann cell motility and indirectly promotes neurite outgrowth. Ogasawara et al. 1990. Microbiol Immunol. 34(12):1025-39. PMID: 2098631. Fabian et al. 1990. Neurology. 40(3 Pt 1):419-22. PMID: 1690363. Uptake of antineuronal IgM by CNS neurons: comparison with antineuronal IgG. Ia restriction specificity of KLH-specific T cells from allogeneic bone marrow chimeras is influenced by histocompatibility at the H-2 and minor histocompatibility loci. Yasumizu et al. 1988. J Immunol. 141(6):2181-6. PMID: 3049801. Development of donor-derived thymic lymphomas after allogeneic bone marrow transplantation in AKR/J mice. Lake et al. 1979. Eur J Immunol. 9(11):875-86. PMID: 393521. Production and characterization of cytotoxic Thy-1 antibody-secreting hybrid cell lines. Detection of T cell subsets. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151015 | Anti-CyclinA [E70.1] |
Key Info
Anti-CyclinA [E70.1]
|
View Tool | |||||||||||||||||||
| 151024 | Anti-Hairy [1/24] |
Key Info
Anti-Hairy [1/24]
|
View Tool | |||||||||||||||||||
| 151037 | Anti-Cdk1 [17 (A17)] |
Key Info
Anti-Cdk1 [17 (A17)]
|
View Tool | |||||||||||||||||||
| 151040 | Anti-CD11 & CD18 [24] |
Key Info
Anti-CD11 & CD18 [24]
|
View Tool | |||||||||||||||||||
| 151020 | Anti-CyclinB1 [V143.1] |
Key Info
Anti-CyclinB1 [V143.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.